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Summary A case of tongue carcinoma (T3N2bM0) in a 35-year-old pregnant
patient was described. She was in the second trimester of pregnancy, although
she had not noticed her pregnancy at the time of the first visit to our hospital. After
cesarean delivery of a boy at a gestation period of 27th week, she was treated with
continuous intra-arterial infusion chemotherapy followed by surgery and postopera-
tive radiotherapy. The patient died of local recurrence at 28 months after the diag-
nosis. Various issues complicating the management of tongue cancer during
pregnancy are discussed.c 2004 Elsevier Ltd. All rights reserved.
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2Introduction
Squamous cell carcinoma (SCC) of the head and
neck during pregnancy is very rare. 1–5 A malig-
nancy discovered during pregnancy is often diffi-
cult to manage; there is almost always a conflict
between the optimal maternal therapy and fetal
well-being. Regarding cancer during pregnancy,741-9409/$ - see front matter c 2004 Elsevier Ltd. All rights rese
oi:10.1016/j.ooe.2004.09.002
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E-mail address: suntago@hsp.md.shinshu-u.ac.jp (T. Koike).prospective randomized clinical trials which may
be regarded as a ‘‘gold-standard’’ for treating
the disease are impossible. 6 Both the patient and
her doctor are often in a dilemma as to the optimal
therapy.Case report
A 35-year-old woman was diagnosed as aphthous
stomatitis by her dentist. She had no treatment for
six months. The ulcerative lesion did not heal, the
pain gradually increased, and she visited our
department.rved.
Figure 1 The lesions of the tongue. (A) The ulcerative
lesion with surrounding induration at the first clinical
presentation. (B) After continuous intra-arterial infusion
chemotherapy. The tumor dramatically decreased in
size.
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ment for diabetes and had been controlled using
diet therapy. She smoked approximately 20 ciga-
rettes a day but seldom drank alcohol. Her father
died of cancer of the larynx at the age of 63.
She was obese, with a height of 150cm and a
weight of 73kg. Intraoral examination revealed an
ulcerated endophytic lesion, measuring approxi-
mately 45mm · 30mm on the right side of the ton-
gue, with surrounding induration (Fig. 1A). Tongue
mobility was limited in forward protrusion. On pal-
pation, many cervical nodes were noticed on the
ipsilateral side, and a CT scan also revealed multi-
ple lymph node swellings. A diagnosis of poorly dif-
ferentiated SCC was made by biopsy. The tumor,
T3N2bM0, had infiltrated into the adjacent muscle.
Systemic neoadjuvant intravenous chemother-
apy was planned with cisplatin and 5-fluoroura-
cil(Fu). Two days after the start of 5-Fu
administration and just before cisplatin infusion,
she told us that she had not menstruated for 6
months. The administration of 5-Fu was canceled,and she was referred to the Obstetrics and Gyn-
ecology Department. She was found to be at a ges-
tation of 26th week 6 days. Our hospital staff,
including us, the obstetrician and pediatrician pro-
posed cesarean section and standard treatment for
advanced tongue carcinoma. Nine days after the
tumor was diagnosed, at a gestation of 27th week
1 day, a boy was delivered by cesarean section
(Fig. 2). Immediately after the delivery, a catheter
was inserted into the right superficial temporal ar-
tery for continuous intra-arterial infusion
chemotherapy.
Chemotherapy with cisplatin (24.4mg/m2 on day
5, and 12.2mg/m2 on day 17) and 5-Fu (15.0mg/m2
for 24h daily until day 28) was performed. The
tumor had dramatically decreased in size by the
end of the chemotherapy (Fig. 1B), showing a more
than 50% decrease in volume. The patient subse-
quently underwent a right hemiglossectomy with
right radical and left supraomohyoid neck dissec-
tion by the pull-through method. The defect was
reconstructed with a radical forearm free flap. His-
topathologically, the surgical specimen showed
well-differentiated SCC (Fig. 3A), although the tu-
mor had been previously diagnosed as poorly differ-
entiated SCC. The patient received postoperative
radiotherapy to the primary site and bilateral cervi-
cal areas.
Approximately 1 year after the completion of
postoperative radiation therapy, the patient re-
vealed a recurrence extending to the submandibu-
lar and submental regions including the mandible.
The patient received two cycles of salvage
chemotherapy. Salvage surgery was performed,
including excision of the bilateral floor of the
mouth, removal of the right submandibular and
submental lesions, partial mandibulectomy and
reconstruction with a deltopectoral flap. The
surgical specimen showed poorly differentiated
SCC (Fig. 3B).
Six months after the second surgery, multiple
mass lesions appeared on the skin of the right sub-
mandibular area. The tumor developed progres-
sively and she died at 28 months after the initial
visit. There was no clinical evidence of distant
metastases. The child grew normally with regular
physical and mental development.Discussion
Oral cancer during pregnancy has been de-
scribed, although it accounts for less than 2% of
all cancers. 4 Cancer during pregnancy entails many
complicating issues such as the relationship
Figure 2 Clinical course in the patient and baby.
Squamous cell carcinoma of the tongue 9between carcinogenesis and pregnancy, maternal
fetal immunological and maternal hormonal inter-
actions, and therapeutic difficulties.
It is speculated that immunological suppression
during gestation, in some way, predisposes the sub-
ject to the malignancy, modifies the biologicalbehavior of the neoplasm, and adversely affects
the clinical course of the malignancy. 7 It is
known that immunosuppressive drugs used in organ
transplant patients increase the risk of cancer and
cause major morbidity and/or mortality. 8 Estro-
gens and progesterone may stimulate latent breast
Figure 3 Photomicrographs of the lesions. (A) Histo-
pathology of the initial surgical specimen showed well-
differentiated SCC (H & E, ·10). (B) Histopathology of
the salvage surgical specimen showed poorly-differenti-
ated SCC (H & E, ·10).
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week of gestation; however, no hormonal recep-
tors in the head and neck epithelial cells existed.
2 It is reputed that there is an increased cancer risk
during pregnancy, that pregnancy stimulates malig-
nancy occurrence, or that pregnancy activates la-
tent cancer. 6,7,9,10 We suppose that both the
patients recovery from immune suppression and
her no longer being pregnant may have contributed
to the dramatic reduction in tumor size effected by
the continuous intra-arterial infusion chemo-
therapy.
The optimal cancer therapy may impose a great
risk on the fetus. Chemotherapy and/or radiother-
apy administered during the first trimester poses
a risk of fetal malformations or spontaneous
abortion. 6,7,9,10 The traditional optimal time of
delivery at the 34th week of gestation might easily
be moved to an earlier date due to recent advances
in perinatology and neonatology. The mortality
rate at 30th week of gestation and later is only1%. In the case of cancer during pregnancy, the fe-
tus may be allowed to mature until the 24th week
of gestation and longer, so that tumor therapy
may be administered as soon as the fetus is deliv-
ered by cesarean section. 6
In the case of cancer during late pregnancy,
three treatment options exist: (1) standard treat-
ment after induced delivery in an attempt to save
the infant, with or without fetal lung maturation;
this entails a high risk of complications, including
hyaline membrane disease or sepsis of the baby,
because of immaturity at birth; (2) no-treatment
of the tumor until after natural birth; it gives prior-
ity to full time delivery of the fetus over the
mothers risks; and (3) starting cancer therapy dur-
ing pregnancy with corresponding risks regarding
both fetal viability and teratogenicity. 3 In the
present case, the patient opted for (1). There
are limited data on the outcome of locally
advanced tongue carcinoma during pregnancy at
present. 1,2,4,5
To our knowledge, this is the first reported case
of continuous intra-arterial infusion chemotherapy
for advanced tongue carcinoma after delivery. We
also discussed the physiologic changes that occur
chemotherapy after the delivery in compliance
with the oncological base.Acknowledgement
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